In a move to protect adolescent girls from cervical cancer, the Government of Sierra Leone today introduced the Human Papilloma Virus (HPV) vaccine to the routine immunisation schedule and launched the start of a campaign to reach 153,991 girls…

Routine immunisation coverage fell for a second consecutive year in 2021 across 57 Gavi-supported countries, although preliminary data shows signs of improvement in early 2022.

The VIS Steering Committee will be convened to provide expert advice across multiple perspectives and deliberations and will provide technical input into the development of Gavi Secretariat’s recommendations to the Programme and Policy Committee…

The COVAX Facility is seeking expressions of interest from the subject matter experts to join the COVAX Independent Product Group. The Independent Product Group (“IPG”) is established to provide scientific advice on COVID-19 vaccines and…

Today’s launch marks the introduction of the rotavirus vaccine, which protects against rotavirus-related diarrhoeal disease, into Nigeria’s routine immunisation programme.

The preventive mass vaccination campaign will target nearly the entire population, ranging from 9 months to 60 years old in 11 departments in Congo.

New analysis of the state of routine immunisation in lower-income countries underlines impact of COVID-19 pandemic, but signs of recovery are emerging.

The escalating global monkeypox outbreak has affected over 18,000 people in 78 countries, across all World Health Organization (WHO) regions. This unprecedented spread has led the WHO Director-General to declare the escalating outbreak a Public…

Gavi is opening its first application window for support in rolling out the first ever malaria vaccine, to protect children against a disease that kills hundreds of thousands in Africa.

Gavi ranked in the highest category out of 50 international development organisations assessed in the 2022 Aid Transparency Index.

Gavi’s Board Meeting emphasizes public health impact with renewed push for routine immunization and reaching zero-dose children.

At least 12.4 million children worldwide are categorised as “zero-dose”,  living in missed communities that cannot access many essential services, including health care.